National Heart and Lung Institute, London, UK and Hammersmith Hospital, London, UK
National Heart and Lung Institute, London, UK and Hammersmith Hospital, London, UK.
Clin Med (Lond). 2021 Mar;21(2):114-118. doi: 10.7861/clinmed.2020-0922.
Recent randomised controlled trials, such as ISCHEMIA and ORBITA, have overturned most of what we were taught in medical school about hospital procedures considered necessary for patients with stable coronary artery disease. In this article, we discuss what these trials mean for physicians and patients considering revascularisation procedures with the hope of reducing the risk of death or alleviating angina.
最近的随机对照试验，如 ISCHEMIA 和 ORBITA，推翻了我们在医学院所学的大多数关于稳定型冠心病患者所需的医院程序的知识。在本文中，我们讨论了这些试验对考虑进行血管重建手术的医生和患者意味着什么，希望能降低死亡风险或减轻心绞痛。
